A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.
Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...
The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...
The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's blockbuster drug Mounjaro ...
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...
As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...
MedPage Today on MSN
GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...
Diabetes significantly impacts oral health, leading to issues like bleeding gums, persistent bad breath, and slow healing.
2hon MSN
A new 'Type 3' diabetes to harm your brain? What your blood sugar levels mean for dementia risk
Research explores \"Type 3\" diabetes, referring to brain insulin resistance, which may increase dementia and Alzheimer's ...
Eli Lilly's popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with ...
The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.
GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results